Zacks Investment Research upgraded shares of Nicox (OTCMKTS:NICXF – Get Rating) from a sell rating to a hold rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. By leveraging their proprietary expertise in nitric […]
Nicox S.A. (OTCMKTS:NICXF – Get Rating)’s stock price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $2.64 and traded as low as $2.09. Nicox shares last traded at $2.09, with a volume of 100 shares traded. Separately, Zacks Investment Research lowered shares […]
Press ReleaseNicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell DiseaseMarch 2nd, 2022 - release at 7:30 am CET Sophia
Press ReleaseNicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical DevelopmentDecember 13, 2021- release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext